Results 111 to 120 of about 14,498 (196)

CD1D wt Allele [PDF]

, 2020
openaire   +1 more source

Natural killer T cells as therapeutic targets for neuroinflammatory disorders. [PDF]

Anim Cells Syst (Seoul)
Park HJ, Lee SW, Kim TC, Park YH, Van Kaer L, Hong S.   +5 more
europepmc   +1 more source

A Novel Sulfatide Analog Recognized by Human iNKT Cells Enhances Polyfunctional Antigen-Specific CD8⁺ T Cell Responses. [PDF]

Eur J Immunol
Hara A, DiSapio J, Coombs M, Keretsu S, Korinfskaya S, Khayrullina G, Joshi V, Alam MM, Kim H, Malik N, Steffke EE, Latifi L, Hancock JC, Spurgeon JD, Ozer BH, Gilbert MR, Howell AR, Terabe M.   +17 more
europepmc   +1 more source

CD1d remodels the tumor-infiltrating myeloid populations controlling antitumor immunity. [PDF]

J Exp Med
Evans L, Conde Poole M, Celik C, Mishra H, Pitcher MJ, Grigoriadis A, Secrier M, Barral P.   +7 more
europepmc   +1 more source

Integrated bioinformatics and machine learning identify key hub genes in early-onset gastric cancer. [PDF]

Front Oncol
Yi S, Chen Q, Wu J, Hou H, Chen H, Zhang W, Zhu K, Liu B, Liang P, Zhang S, Yang D.   +10 more
europepmc   +1 more source

Adrenergic receptors; CD1D [PDF]

Science-Business eXchange, 2011
openaire   +1 more source

All-Hydrocarbon Macrocycle Enables Highly Potent Th1-Biased NKT Cell Agonists for Immunotherapy. [PDF]

JACS Au
Sun QN, Wen Y, Wu YH, Mei DX, Liu ZQ, An XY, Guo J.   +6 more
europepmc   +1 more source

Paraformaldehyde-Induced Vesiculation Preserves Native Membrane Physiological States Critical for T‑Cell Activation. [PDF]

ACS Omega
Shrestha D, Veerapongchai V, Eggeling C.
europepmc   +1 more source

Lenalidomide boosts CD1d-Vδ2 bispecific antibody-engaged Vγ9Vδ2-T cell effector functions via CD28, Notch signaling and IL-2 release. [PDF]

J Immunother Cancer
de Jong M, Veth M, Brachtlová T, King LA, Saura-Esteller J, Bechler TM, van Helden PM, Alhan C, Lameris R, de Gruijl TD, van der Vliet HJ.   +10 more
europepmc   +1 more source

FAP-Directed CAR-NKT Cells for Multi-Target Suppression of Atherosclerotic Progression. [PDF]

Circ Res
Zhu E, Li YR, Cho JM, Kropp R, Zhang Y, Sanaiha Y, Kwon OJ, Zhu Y, Park SK, Arianpour B, Justo M, Zhao P, Wang S, Gu M, Benharash P, Yang L, Hsiai TK.   +16 more
europepmc   +1 more source